Related Experiment Video
Updated: Aug 13, 2026

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
Middle Meningeal Artery Embolization for the Management of Chronic Subdural Hematoma
Balakrishna Aggipothu1, Saikanth Deepalam2, Sagar Badachi3
1Intervention Neuroradiology, St John's Medical College and Hospital, Bengaluru, IND.
Insights
Middle Meningeal Artery (MMA) embolization is a safe and effective treatment for chronic subdural hematoma (cSDH). This procedure led to complete resolution in most patients, significantly reducing recurrence risks.
Area of Science:
- Neurosurgery
- Interventional Radiology
- Vascular Neurology
Background:
- Chronic subdural hematoma (cSDH) arises from neovascularization within the subdural membrane.
- Recurrence is common, often linked to the Middle Meningeal Artery (MMA).
Purpose of the Study:
- To evaluate the safety and efficacy of MMA embolization for chronic subdural hematoma.
- To assess clinical and radiological outcomes following MMA embolization.
Main Methods:
- Retrospective review of 29 patients undergoing MMA embolization for cSDH (2018-2022).
- Analysis included clinical history, imaging, procedural details, and outcomes.
- Follow-up imaging (MRI/CT) and modified Rankin Scale (mRS) were assessed.
Main Results:
- Twenty-nine MMA embolization procedures were successfully performed.
- Complete radiological resolution occurred in 25 patients (86%).
- Excellent functional outcome (mRS 0) at 90 days was observed in 86% of patients.
Conclusions:
- MMA embolization is a feasible and effective treatment for chronic and recurrent cSDH.
- The procedure demonstrates a favorable safety profile with high resolution rates.
Abstract:
Introduction Chronic subdural hematoma (cSDH) results from neovascularization of the subdural capsular membrane and embolization of the Middle Meningeal Artery (MMA) helps inhibit the same and prevent recurrence. Materials and methods We retrospectively reviewed the endovascular management for chronic SDH in 29 patients between 2018 to 2022. The parameters analyzed were clinical history, radiologic imaging findings, procedure details, and angiographic and clinical outcomes. Results Twenty-nine MMA embolization procedures were done. Follow-up MRI or CT done in 28 subjects, showed complete resolution in 25 patients and a significant reduction in bilateral SDH in three patients. One patient died due to renal failure and aspiration pneumonia-related complications. Ninety days mRS (modified Rankin scale) was 0 in 25 patients (86%), one in two patients, and two in one patient. Conclusions MMA embolization for chronic SDH is a feasible, safe, and effective technique in patients with chronic and recurrent SDH.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

